7575.T Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 Mai 2024 @ 08:15):

Japan Lifeline Co., Ltd., a medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan...

Stats
Tagesvolumen	843 000
Durchschnittsvolumen	196 158
Marktkapitalisierung	93.74B
EPS	¥0 ( 2024-02-01 )
Nächstes Ertragsdatum	( ¥0 ) 2024-05-08
Last Dividend	¥38.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	12.67
ATR14	¥0.991 (0.08%)

Volumen Korrelation

Lang: 0.02 (neutral)

Kurz: -0.95 (very strong negative)

Signal:(48.827) Neutral

Japan Lifeline Co., Ltd. Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Japan Lifeline Co., Ltd. Korrelation - Währung/Rohstoff

0.49
( neutral )

0.21
( neutral )

0.10
( neutral )

0.58
( weak )

-0.35
( neutral )

-0.65
( moderate negative )

Japan Lifeline Co., Ltd. Finanzdaten

Annual	2023
Umsatz:	¥51.38B
Bruttogewinn:	¥30.38B (59.12 %)
EPS:	¥98.72

FY	2023
Umsatz:	¥51.38B
Bruttogewinn:	¥30.38B (59.12 %)
EPS:	¥98.72

FY	2022
Umsatz:	¥51.75B
Bruttogewinn:	¥29.90B (57.77 %)
EPS:	¥88.22

FY	2022
Umsatz:	¥51.47B
Bruttogewinn:	¥28.84B (56.02 %)
EPS:	¥93.13

Financial Reports:

No articles found.

Japan Lifeline Co., Ltd. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥0 (N/A)	¥0 (N/A)	¥38.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Japan Lifeline Co., Ltd. Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 3.10 - Decrease likely (38.03%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥3.13	2000-03-28
Last Dividend	¥38.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	22	--
Total Paid Out	¥232.75	--
Avg. Dividend % Per Year	0.00%	--
Score	2.96	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	3.10
Div. Directional Score	7.47	--

Next Divdend (Est)
(2025-05-26)

¥0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

2.96

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
7976.T	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
7212.T	Ex Dividend Junior	2023-09-28	Annually	0.00%
6458.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
5464.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
4461.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
3641.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
2897.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
1716.T	Ex Dividend Knight	2024-06-27	Annually	0.00%
9308.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
8285.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.146	1.500	7.07	10.00	[0 - 0.5]
returnOnAssetsTTM	0.102	1.200	6.59	7.91	[0 - 0.3]
returnOnEquityTTM	0.133	1.500	9.63	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	3.02	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	1.831	0.800	3.94	3.15	[0.8 - 2.5]
cashRatioTTM	0.894	1.500	6.15	9.22	[0.2 - 2]
debtRatioTTM	0.0549	-1.500	9.08	-10.00	[0 - 0.6]
interestCoverageTTM	514.15	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	23.76	2.00	2.08	4.16	[0 - 30]
freeCashFlowPerShareTTM	23.76	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.0695	-1.500	9.72	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.591	1.000	3.48	3.48	[0.2 - 0.8]
operatingProfitMarginTTM	0.200	1.000	8.00	8.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.442	1.000	8.66	8.66	[0.2 - 2]
assetTurnoverTTM	0.699	0.800	8.67	6.94	[0.5 - 2]
Total Score				11.85

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	12.49	1.000	8.84	0	[1 - 100]
returnOnEquityTTM	0.133	2.50	9.76	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	23.76	2.00	2.08	10.00	[0 - 30]
dividendYielPercentageTTM	3.36	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	23.76	2.00	2.08	4.16	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.0456	1.500	-3.03	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0347	1.000	-1.633	0	[0.1 - 0.5]
Total Score				3.10

Japan Lifeline Co., Ltd.

Japan Lifeline Co., Ltd., a medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan. The company's cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, and radio-frequency transseptal needles. Its cardiovascular and endografting products consist of vascular and open stent grafts, and abdominal stent-grafts; and transvascular intervention products include PTCA and PTA guide wires, PTCA balloon catheters, radiofrequency wires, and atrial septal defect closure devices. The company offers gastrointestinal intervention products that consist of radiofrequency ablation systems, self-expandable colonic stents, and endoscopic guidewires. Japan Lifeline Co., Ltd. was incorporated in 1981 and is headquartered in Tokyo, Japan.

Echtzeitaktualisierungen für Japan Lifeline Co., Ltd. [7575.T]

Upcoming Earnings Alert

Japan Lifeline Co., Ltd. Dividend Information - Ex Dividend Junior

Dividend Commentary

Top 10 dividend Companies for JPX

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)